Low levels of ROS promote MMP expression and enhance tumor invasion capability by activating the NF-κB and AP-1 pathways, while high levels of ROS inhibit tumor progression through inducing oxidative damage and apoptosis (29). The gene discussed is NFKB1; the disease is neoplasm.